Quarterly Result12 Aug 2025, 03:10 pm
Windlas Biotech Ltd Announces Q1 2025 Financial Results with Net Profit of 176.64 Million INR
AI Summary
Windlas Biotech Ltd, a pharmaceutical company, announced its consolidated unaudited financial results for the quarter ended June 30, 2025. The company reported a revenue from operations of 2,100.90 million INR, a net profit of 176.64 million INR, and a total comprehensive income of 164.40 million INR attributable to owners. The company operates in one primarily reportable segment, 'Pharmaceuticals'. The financial results have been reviewed by the audit committee and approved by the board of directors.
Key Highlights
- Revenue from operations for Q1 2025 is 2,100.90 million INR
- Net profit for Q1 2025 is 176.64 million INR
- Total comprehensive income for Q1 2025 is 164.40 million INR attributable to owners
- The company operates in one reportable segment, 'Pharmaceuticals'
- Financial results have been reviewed by the audit committee and approved by the board of directors